PrestiBio URINALASYS TEST STRIP 10 PARAMETERS REF 900-10
Publicado el 1 de noviembre de 2023 · Inicio del retiro: 22 de mayo de 2023
Resumen
FDA registra el retiro Z-0057-2024 de dispositivos médicos de Clase II, publicado el 1 de noviembre de 2023 e iniciado el 22 de mayo de 2023. Empresa responsable: Universal Meditech Inc.; Estado: En curso; Cantidad reportada: Unknown; Lote: Model Number: 900-10 UDI-DI Code: None Lot Numbers: All products manufactured after March 2021. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Ongoing — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS® SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events.
Qué hacer
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Universal Meditech Inc.
- Distribuidor
- U.S.: CA, FL, IL, LA, NJ, NY, TX and WY O.U.S.: Taiwan
- Lote
- Model Number: 900-10 UDI-DI Code: None Lot Numbers: All products manufactured after March 2021
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAPrestiBio Rapid Detection Pregnancy Test Midstream REF 100-17 3 TESTS1 de noviembre de 2023
- FDASynCardia 50cc TAH-t, Clinical, REF 570500, Sterile EO1 de noviembre de 2023
- FDAPenzeys Brady Street Cheese Sprinkle. Item 20756. net wt 2.2 oz (62g). Penzeys Spices, Wauwatosa, WI 53222.1 de noviembre de 2023
- FDAMonoject 20 mL Syringe Luer-Lock Tip Soft Pack1 de noviembre de 2023
- FDAOrganic Protein & 50 Superfoods Protein Powder with Probiotic - Chocolate flavor1 de noviembre de 2023
- FDAGrafton DMB Matrix, Model Numbers: a) T42200, b) T42210; Demineralized Bone Matrix1 de noviembre de 2023
Preguntas sobre este retiro
¿PrestiBio URINALASYS TEST STRIP 10 PARAMETERS REF 900-10 fue retirado del mercado?
Sí. FDA publicó el retiro Z-0057-2024 el 1 de noviembre de 2023. Peligro reportado: Universal Meditech Inc. was violatively distributing PrestiBio" Breastmilk Alcohol Test Strip, DiagnosUS® SARS-CoV-2 Antibody (IgG/IgM) Test, HealthyWiser KetoFast" Ketone Test Strips and PrestiBio" Ketone Test Strips without marketing authorization. UMI is also recall their tests because they are going out of business and would not be able to continue fulfilling any post-market responsibilities of these distributed products. UMI claims to hold 510(k)s for the other devices, purchased the intellectual property in 2015 from the previous 510(k) holder, but FDA has been unable to verify this information. The devices may have unknown performance characteristics because the firm is unable to provide any documentation that the devices were manufactured in conformance with the Quality System regulation, including documentation (e.g., DHF) that the distributed devices had not been modified since original clearance in a way that could impact their safety and effectiveness, documentation of controlled storage temperature/humidity, and post-market surveillance documentation, such as complaints and adverse events.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit